PRESS-RELEASE ·Filed Jul 23, 2026

INDV

Indivior Pharmaceuticals Inc.
NEUTRAL
Impact 2/10
Horizondays Processed2mo ago WireGlobeNewswire
Press release: earnings
Actionable Insight • Neutral

Monitor the upcoming Q2 2026 earnings release on August 4 for actual financial results and guidance updates. No immediate trading signal from this date announcement.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d
INDV ▼ -6.74% at T+20d
NEUTRAL call ✗ call lost -6.74% · α vs SPY -10.05% · entry $40.51 → $37.78
Next anchor: T+60d in 14d
Latest observation: T+47 -14.11% FF3 residual α
Entry anchored
Jul 23, 09:59 AM ET
via exchange tick
T+1d
+0.04%
call +0.04% · α -0.06%
$40.53
settled 2mo ago
T+5d
-0.72%
call -0.72% · α -1.19%
$40.22
settled 2mo ago
T+20d
-6.74%
call -6.74% · α -10.05%
$37.78
settled 6w ago
T+60d
—
call — · α —
—
in 14d

Price Chart

Loading chart...

Executive Summary

Indivior announced it will report Q2 2026 financial results on August 4, 2026, with a webcast at 8:00 AM EDT. This is a routine earnings date notice with no financial data disclosed.

Key Facts

  • Indivior to report Q2 2026 results on August 4, 2026 at 7:00 AM EDT
  • Webcast presentation at 8:00 AM EDT following the release
  • No financial results or guidance provided in this filing

Financial Impact

No financial data in this filing

Risk Factors

  • No specific risks identified from this routine filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3332299
18 reports for INDV
Performance horizon
100% Hit rate 7 of 7 directional calls best @ T+60▲ +21.73%Apr 24, 2026
Filters
Rows
Reports for INDV — sortable, filterable
TypeNow
Sep 14, 2026
18d ago
EFFECT
NEUTRAL ★ 4/10
$34.47 $35.53▲ +3.08%▲ +2.97%$35.71 (+3.60%)
Aug 28, 2026
4w ago
S-4
NEUTRAL ★ 6/10
$34.93 $34.32▼ −1.75%▼ −1.60%$35.71 (+2.23%)
Aug 3, 2026
8w ago
425 / 8-K
BULLISH ★ 8/10
$37.37 $38.47▲ +2.94%▲ +0.92%$35.71 (−4.44%)
Aug 3, 2026
8w ago
425
BULLISH ★ 8/10
$37.37 $38.47▲ +2.94%▲ +0.92%$35.71 (−4.44%)
Aug 3, 2026
8w ago
8-K
BULLISH ★ 8/10
$37.37 $38.47▲ +2.94%▲ +0.92%$35.71 (−4.44%)
Aug 3, 2026
8w ago
425 / 8-K
BULLISH ★ 7/10
$37.37 $38.47▲ +2.94%▲ +0.92%$35.71 (−4.44%)
Jul 23, 2026
10w ago
Press Release
NEUTRAL ★ 2/10
$40.51 $40.22▼ −0.72%▼ −1.19%$35.71 (−11.85%)
Jun 12, 2026
16w ago
Insider Cluster
NEUTRAL ★ 4/10
$38.40 $38.32▼ −0.21%▲ +1.17%$35.71 (−7.01%)
May 15, 2026
20w ago
8-K
NEUTRAL ★ 3/10
$36.54 $37.81▲ +3.48%▲ +1.86%$35.71 (−2.27%)
May 4, 2026
21w ago
8-K
NEUTRAL ★ 3/10
$38.98 $38.84▼ −0.36%▼ −3.30%$35.71 (−8.39%)
Showing 10 of 18

US Market Status

Market Closed — Opens Mon (64h 38m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 23, 2026